EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Serum brain-derived tau in lacunar stroke and cerebral small vessel disease

Thomas Gattringer iD, Melanie Haidegger iD, Cansu Tafrali iD, Maria Martinez-Serrat iD, Daniela Pinter iD, Simon Fandler-Höfler iD, Markus Kneihsl iD, Stephan Seiler iD, Sebastian Eppinger, Christian Kiss iD, Roberta Bichler, Michaela T Haindl und 3 weitere

European Stroke Journal · 02.11.2026 · 11 (11)

DOI: 10.1093/esj/aakag133 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Stroke Journal, online erschienen am 02.11.2026. Verfasst von Thomas Gattringer und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Medical University of Graz, Graz, Austria. Hauptthemen laut MEDLINE: Stroke, Lacunar, Cerebral Small Vessel Diseases, tau Proteins, Brain. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Austrian Science Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Brain-derived tau (BD-tau) selectively quantifies tau of central nervous system origin in blood and has demonstrated strong correlations with infarct volume and functional outcome in general ischaemic stroke, but data in lacunar stroke and cerebral small vessel disease (CSVD) are lacking. Patients and methods In a prospectively collected cohort of 101 lacunar stroke patients with an MRI-confirmed recent small subcortical infarct (RSSI) and 47 controls, we measured serum BD-tau using the HD-X SIMOA platform at baseline and 3 and 15 months after stroke. We examined associations of BD-tau with infarct size, chronic CSVD neuroimaging features (white matter hyperintensities [WMHs], lacunes, microbleeds, total SVD score), CSVD progression on follow-up MRI and functional outcome.

Results

Baseline serum BD-tau was higher in RSSI patients than controls (median 9.54 [7.32–12.20] vs 7.75 [6.18–9.44] pg/mL; P = .003) and correlated with infarct diameter (rs = 0.222, P = 0.039). Brain-derived tau did not correlate with time from stroke symptom onset to blood sampling (rs = 0.150, P = .179). Brain-derived tau was not associated with chronic CSVD neuroimaging features (WMHs, lacunes, microbleeds, SVD score; all P > .05) at any timepoint. Longitudinally, BD-tau returned to control levels by 3 months (P = .374) and remained stable at 15 months (P = .985). Brain-derived tau was neither associated with new vascular MRI lesions on follow-up nor functional neurological outcome.

Conclusion

Serum BD-tau is elevated acutely in CSVD-related RSSI, correlates with infarct size and normalises by 3 months. Brain-derived tau was not associated with chronic CSVD neuroimaging features or disease progression, suggesting sensitivity to acute neuronal injury rather than chronic or progressive CSVD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stroke, LacunarCerebral Small Vessel Diseasestau ProteinsBrainHumansFemaleMaleAgedMagnetic Resonance ImagingMiddle AgedProspective StudiesDisease ProgressionBiomarkers

Stichwörter der Autor:innen

brain-derived taucerebral small vessel diseaselacunar strokerecentsmall subcortical infarct

Substanzen

tau ProteinsBiomarkers

Autor:innen und Institutionen

  • Department of Neurology, Medical University of Graz, Graz, Austria.
  • Department of Neurology, University Hospital Wiener Neustadt - Hochegg, Wiener Neustadt, Austria.
  • Department of Medicine, Danube Private University, Krems, Austria.
  • Division of Neuroradiology, Vascular and Interventional Radiology, Department of Radiology, Medical University of Graz, Graz, Austria.

ORCID-Profile: Thomas Gattringer, Melanie Haidegger, Cansu Tafrali, Maria Martinez-Serrat, Daniela Pinter, Simon Fandler-Höfler, Markus Kneihsl, Stephan Seiler, Christian Kiss, Stefan Ropele, Michael Khalil

Förderung

  • Austrian Science Fund

Zitieren

APA

Gattringer, T., Haidegger, M., Tafrali, C., Martinez-Serrat, M., Pinter, D., Fandler-Höfler, S., Kneihsl, M., Seiler, S., Eppinger, S., Kiss, C., Bichler, R., Haindl, M. T., Ropele, S., Enzinger, C., & Khalil, M. (2026). Serum brain-derived tau in lacunar stroke and cerebral small vessel disease. European Stroke Journal, 11(11). https://doi.org/10.1093/esj/aakag133

Vancouver

Gattringer T, Haidegger M, Tafrali C, Martinez-Serrat M, Pinter D, Fandler-Höfler S, et al. Serum brain-derived tau in lacunar stroke and cerebral small vessel disease. European Stroke Journal. 2026;11(11). doi:10.1093/esj/aakag133

BibTeX
@article{Gattringer2026,
  author = {Gattringer, Thomas and Haidegger, Melanie and Tafrali, Cansu and Martinez-Serrat, Maria and Pinter, Daniela and Fandler-Höfler, Simon and Kneihsl, Markus and Seiler, Stephan and Eppinger, Sebastian and Kiss, Christian and Bichler, Roberta and Haindl, Michaela T and Ropele, Stefan and Enzinger, Christian and Khalil, Michael},
  title = {Serum brain-derived tau in lacunar stroke and cerebral small vessel disease},
  journal = {European Stroke Journal},
  year = {2026},
  volume = {11},
  number = {11},
  doi = {10.1093/esj/aakag133}
}
Kostenlos starten →